Prospective combined analysis of spirometry, impulse oscillation, and chest tomography for the effect of salmeterol/fluticasone (SFC) in COPD
Not Applicable
- Conditions
- Chronic Obstructive Pulmonary Disease (COPD)
- Registration Number
- JPRN-UMIN000004097
- Lead Sponsor
- agoya University Graduate School of Medicine
- Brief Summary
The clinical trial was discontinued due to small numbers.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 34
Inclusion Criteria
Not provided
Exclusion Criteria
1. any disease with possible air flow limitation defined as below 2.defined as below; bronchial asthma, diffuse pan bronchitis, sinobronchial syndrome, bronchial ectasis, tuberculosis, pneumoconiosis, lymphangioleiomyomatosis, congestic heart failure, and interstitial pneumonia detected by chest Xray 3. contraindication to SFC treatment
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method inspiratory capacity
- Secondary Outcome Measures
Name Time Method 1) subjective dyspnea 2)spirometry 3)R5, R20, R5-R20, and X5 on oscillation 4)Total lung capacity and emphysema lung volume on inspiratory phase expiratory phase by chest tomograpghy 5) subanalysis of lung hyperinflation and subjective dyspnea in both responder and non-responder for SFC